CD24+/CD38- As New Prognostic Marker for Non-Small Cell Lung Cancer

Multidisciplinary Respiratory Medicine - United Kingdom
doi 10.1186/2049-6958-8-65
Full Text
Abstract

Available in full text

Date
Authors
Publisher

PAGEPress Publications

Related search

Serum Pleiotrophin as a Diagnostic and Prognostic Marker for Small Cell Lung Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Prognostic Gene Signatures for Non-Small-Cell Lung Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

A Meta-Analysis for CXCR4 as a Prognostic Marker and Potential Drug Target in Non-Small Cell Lung Cancer

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

P3.16-01 a Multi-Omic Study Reveals BTG2 as a Reliable Prognostic Marker for Early-Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Significance of CD276 in Non-Small Cell Lung Cancer

Open Medicine (Poland)
Medicine
2019English

New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2020English

Prognostic Significance of FoxM1 Expression in Non-Small Cell Lung Cancer

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy